Under construction – not a live service
Sign in
Taking peoplePhase 4

The Effect of PAP on ISSHL Comorbided With OSA

Key facts

Phase
Phase 4

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Source: NCT04192656, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Beijing Tsinghua Chang Gung Hospital
Trial code
NCT04192656
Record updated
10 December 2019
Original description
This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.Read full original descriptionShow less

The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Inclusion: aged >= 18 and <= 70,; diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI > 15/h,; diagnosed with ISSHL by AAO-HNS 2019 criteria,; ISSHL onset within 1 week.

Exclusion: previously regularly treated with PAP; with severe comorbid diseases,; sudden hearing loss with certain causes,; pregnant or breast-feeding women,; AHI <= 15/h,; hearing threshold recovered > 50% when included,.

ClinicalTrials.gov NCT04192656